{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:59:54Z","timestamp":1740124794323,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41434-022-00337-2","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T02:03:02Z","timestamp":1650592982000},"page":"477-478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Micro-dystrophin gene constructs for repairing heart and muscle function in rats: the smaller is enough?"],"prefix":"10.1038","volume":"29","author":[{"given":"Petra Lujza","family":"Szabo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4652-1998","authenticated-orcid":false,"given":"Attila","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"337_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7:13.","journal-title":"Nat Rev Dis Primers"},{"key":"337_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/00019052-200310000-00003","volume":"16","author":"F Muntoni","year":"2003","unstructured":"Muntoni F. Cardiomyopathy in muscular dystrophies. Curr Opin Neurol. 2003;16:577\u201383.","journal-title":"Curr Opin Neurol"},{"key":"337_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77\u201393.","journal-title":"Lancet Neurol"},{"key":"337_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11940-014-0287-4","volume":"16","author":"N Goemans","year":"2014","unstructured":"Goemans N, Buyse G. Current treatment and management of dystrophinopathies. Curr Treat Options Neurol. 2014;16:287.","journal-title":"Curr Treat Options Neurol"},{"key":"337_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","volume":"25","author":"JR Chamberlain","year":"2017","unstructured":"Chamberlain JR, Chamberlain JS. Progress toward gene therapy for Duchenne muscular dystrophy. Mol Ther. 2017;25:1125\u201331.","journal-title":"Mol Ther"},{"key":"337_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26830-7","volume":"12","author":"CH Hakim","year":"2021","unstructured":"Hakim CH, Kumar SRP, Perez-Lopez DO, Wasala NB, Zhang D, Yue Y, et al. Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models. Nat Commun. 2021;12:6769.","journal-title":"Nat Commun"},{"key":"337_CR7","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.121.054628","volume":"144","author":"J Li","year":"2021","unstructured":"Li J, Wang K, Zhang Y, Qi T, Yuan J, Zhang L, et al. Therapeutic exon skipping through a CRISPR-guided cytidine deaminase rescues dystrophic cardiomyopathy in vivo. Circulation. 2021;144:1760\u201376.","journal-title":"Circulation"},{"key":"337_CR8","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","volume":"26","author":"D Duan","year":"2018","unstructured":"Duan D. Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy. Mol Ther. 2018;26:2337\u201356.","journal-title":"Mol Ther"},{"key":"337_CR9","doi-asserted-by":"publisher","unstructured":"Bourdon A, Fran\u00e7ois V, Zhang L, Lafoux A, Fraysse B, Toumaniantz G, et al. Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMDmdx rat model. Gene Ther. 2022 https:\/\/doi.org\/10.1038\/s41434-022-00317-6.","DOI":"10.1038\/s41434-022-00317-6"},{"key":"337_CR10","doi-asserted-by":"publisher","first-page":"e110371","DOI":"10.1371\/journal.pone.0110371","volume":"9","author":"T Larcher","year":"2014","unstructured":"Larcher T, Lafoux A, Tesson L, Remy S, Thepenier V, Francois V, et al. Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy. PLoS ONE. 2014;9:e110371.","journal-title":"PLoS ONE"},{"key":"337_CR11","doi-asserted-by":"publisher","unstructured":"Szab\u00f3 PL, Ebner J, Koenig X, Hamza O, Watzinger S, Trojanek S, et al. Cardiovascular phenotype of the Dmdmdx rat - a suitable animal model for Duchenne muscular dystrophy. Dis Model Mech. 2021;14:dmm047704 https:\/\/doi.org\/10.1242\/dmm.047704.","DOI":"10.1242\/dmm.047704"},{"key":"337_CR12","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/hmg\/ddab133","volume":"30","author":"H Wang","year":"2021","unstructured":"Wang H, Marrosu E, Brayson D, Wasala NB, Johnson EK, Scott CS, et al. Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin. Hum Mol Genet. 2021;30:1321\u201336.","journal-title":"Hum Mol Genet"},{"key":"337_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCRESAHA.107.162982","volume":"102","author":"B Bostick","year":"2008","unstructured":"Bostick B, Yue Y, Long C, Duan D. Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin\/utrophin expression. Circ Res. 2008;102:121\u201330.","journal-title":"Circ Res"},{"key":"337_CR14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/hmg\/ddaa015","volume":"29","author":"TA Meyers","year":"2020","unstructured":"Meyers TA, Heitzman JA, Townsend D. DMD carrier model with mosaic dystrophin expression in the heart reveals complex vulnerability to myocardial injury. Hum Mol Genet. 2020;29:944\u201354.","journal-title":"Hum Mol Genet"},{"key":"337_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/ehjci\/jev161","volume":"17","author":"A Florian","year":"2016","unstructured":"Florian A, Rosch S, Bietenbeck M, Engelen M, Stypmann J, Waltenberger J, et al. Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging. 2016;17:326\u201333.","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00337-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00337-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00337-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T23:04:00Z","timestamp":1663542240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00337-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["337"],"URL":"https:\/\/doi.org\/10.1038\/s41434-022-00337-2","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"type":"print","value":"0969-7128"},{"type":"electronic","value":"1476-5462"}],"subject":[],"published":{"date-parts":[[2022,4,22]]},"assertion":[{"value":"5 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}